Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine

Supporting evidence

• Review decision

• Review decision - December 2020

• Review decision paper (PDF 292 KB)

  Published:

  09 December 2020

• Stakeholder list (PDF 141 KB)

  Published:

  09 December 2020